MYHFGIPSFCSGIE-LROBGIAVSA-N
C27H33F3N8O2 — CID 143578287
Data last refreshed: (MolForge compound catalog, from PubChem)
About MYHFGIPSFCSGIE-LROBGIAVSA-N
MYHFGIPSFCSGIE-LROBGIAVSA-N (PubChem CID 143578287) has the molecular formula C27H33F3N8O2 and a molecular weight of 558.61 g/mol. Its IUPAC name is 4-[[4-[[(3S)-3-(cyanomethylcarbamoyl)cyclopentyl]amino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide.
Molecular Properties
| Compound Name | MYHFGIPSFCSGIE-LROBGIAVSA-N |
|---|---|
| PubChem CID | 143578287 |
| Molecular Formula | C27H33F3N8O2 |
| Molecular Weight | 558.61 g/mol |
| Exact Mass | 558.27 |
| IUPAC Name | 4-[[4-[[(3S)-3-(cyanomethylcarbamoyl)cyclopentyl]amino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide |
| SMILES | CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(NC4CC[C@H](C(=O)NCC#N)C4)n3)cc2)CC1 |
| InChI | InChI=1S/C27H33F3N8O2/c1-37-13-9-21(10-14-37)38(2)25(40)17-3-6-19(7-4-17)35-26-33-16-22(27(28,29)30)23(36-26)34-20-8-5-18(15-20)24(39)32-12-11-31/h3-4,6-7,16,18,20-21H,5,8-10,12-15H2,1-2H3,(H,32,39)(H2,33,34,35,36)/t18-,20?/m0/s1 |
| InChIKey | MYHFGIPSFCSGIE-LROBGIAVSA-N |
| XLogP | 3.63 |
| TPSA | 126.28 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.61 |
| LogP ≤ 5 | 3.63 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'cyanamide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143578287 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.